Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial (LBA 5)
Ning Li, Jianqing Zhu, Rutie Yin, Jing Wang, Lingya Pan, Beihua Kong, Hong Zheng, Jihong Liu, Xiaohua Wu, Li Wang, Yi Huang, Xiuli Wang, Dongling Zou, Hongqin Zhao, Chunyan Wang, Weiguo Lu, Lin An, Ge Lou, Guiling Li, Pengpeng Qu, Hongying Yang, Xiaoa Zhen, Wenzhao Hang, Jianmei Hou, Lingying Wu
Topics & Concepts
MedicineInternal medicineClinical endpointOvarian cancerRandomized controlled trialProgression-free survivalOncologyChemotherapyGastroenterologyCancerPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentAdvanced Electron Microscopy Techniques and Applications